Your browser doesn't support javascript.
loading
TGF-ß promotes microtube formation in glioblastoma through thrombospondin 1.
Joseph, Justin V; Magaut, Capucine R; Storevik, Simon; Geraldo, Luiz H; Mathivet, Thomas; Latif, Md Abdul; Rudewicz, Justine; Guyon, Joris; Gambaretti, Matteo; Haukas, Frida; Trones, Amalie; Rømo Ystaas, Lars A; Hossain, Jubayer A; Ninzima, Sandra; Cuvellier, Sylvain; Zhou, Wenjing; Tomar, Tushar; Klink, Barbara; Rane, Lalit; Irving, Bronwyn K; Marrison, Joanne; O'Toole, Peter; Wurdak, Heiko; Wang, Jian; Di, Zhang; Birkeland, Even; Berven, Frode S; Winkler, Frank; Kruyt, Frank A E; Bikfalvi, Andreas; Bjerkvig, Rolf; Daubon, Thomas; Miletic, Hrvoje.
Afiliação
  • Joseph JV; Department of Clinical Medicine, University of Aarhus, Aarhus, Denmark.
  • Magaut CR; Department of Biomedicine, University of Bergen, Bergen, Norway.
  • Storevik S; INSERM, LAMC, U1029, University of Bordeaux, Pessac, France.
  • Geraldo LH; Department of Biomedicine, University of Bergen, Bergen, Norway.
  • Mathivet T; Department of Pathology, Haukeland University Hospital, Bergen, Norway.
  • Latif MA; INSERM U970, Paris Cardiovascular Research Center, Paris, France.
  • Rudewicz J; INSERM U970, Paris Cardiovascular Research Center, Paris, France.
  • Guyon J; Department of Biomedicine, University of Bergen, Bergen, Norway.
  • Gambaretti M; Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Haukas F; Department of Biomedicine, University of Bergen, Bergen, Norway.
  • Trones A; INSERM, LAMC, U1029, University of Bordeaux, Pessac, France.
  • Rømo Ystaas LA; INSERM, LAMC, U1029, University of Bordeaux, Pessac, France.
  • Hossain JA; Department of Biomedicine, University of Bergen, Bergen, Norway.
  • Ninzima S; Department of Biomedicine, University of Bergen, Bergen, Norway.
  • Cuvellier S; Department of Biomedicine, University of Bergen, Bergen, Norway.
  • Zhou W; Department of Biomedicine, University of Bergen, Bergen, Norway.
  • Tomar T; Department of Pathology, Haukeland University Hospital, Bergen, Norway.
  • Klink B; Department of Biomedicine, University of Bergen, Bergen, Norway.
  • Rane L; Department of Biological Sciences, University of Bergen, Bergen, Norway.
  • Irving BK; CNRS, IBGC, UMR5095, University of Bordeaux, Bordeaux, France.
  • Marrison J; Department of Biomedicine, University of Bergen, Bergen, Norway.
  • O'Toole P; Department of Blood Transfusion, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, P.R. China.
  • Wurdak H; Department of Neurosurgery, Qilu Hospital of Shandong University and Institute of Brain and Brain-Inspired Science, Shandong University; Shandong Key Laboratory of Brain Function Remodeling, Jinan, Shandong, P.R. China.
  • Wang J; PamGene International B.V., BJ 's-Hertogenbosch, the Netherlands.
  • Di Z; Department of Biomedicine, University of Bergen, Bergen, Norway.
  • Birkeland E; National Center of Genetics (NCG), Laboratoire national de santé (LNS), Dudelange, Luxembourg.
  • Berven FS; Department of Oncology, Luxembourg Institute of Health (LIH), Strassen, Luxembourg.
  • Winkler F; Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Kruyt FAE; School of Medicine, University of Leeds, Leeds, UK.
  • Bikfalvi A; Department of Biology, University of York, York, UK.
  • Bjerkvig R; Department of Biology, University of York, York, UK.
  • Daubon T; School of Medicine, University of Leeds, Leeds, UK.
  • Miletic H; Department of Biomedicine, University of Bergen, Bergen, Norway.
Neuro Oncol ; 24(4): 541-553, 2022 04 01.
Article em En | MEDLINE | ID: mdl-34543427
ABSTRACT

BACKGROUND:

Microtubes (MTs), cytoplasmic extensions of glioma cells, are important cell communication structures promoting invasion and treatment resistance through network formation. MTs are abundant in chemoresistant gliomas, in particular, glioblastomas (GBMs), while they are uncommon in chemosensitive IDH-mutant and 1p/19q co-deleted oligodendrogliomas. The aim of this study was to identify potential signaling pathways involved in MT formation.

METHODS:

Bioinformatics analysis of TCGA was performed to analyze differences between GBM and oligodendroglioma. Patient-derived GBM stem cell lines were used to investigate MT formation under transforming growth factor-beta (TGF-ß) stimulation and inhibition in vitro and in vivo in an orthotopic xenograft model. RNA sequencing and proteomics were performed to detect commonalities and differences between GBM cell lines stimulated with TGF-ß.

RESULTS:

Analysis of TCGA data showed that the TGF-ß pathway is highly activated in GBMs compared to oligodendroglial tumors. We demonstrated that TGF-ß1 stimulation of GBM cell lines promotes enhanced MT formation and communication via calcium signaling. Inhibition of the TGF-ß pathway significantly reduced MT formation and its associated invasion in vitro and in vivo. Downstream of TGF-ß, we identified thrombospondin 1 (TSP1) as a potential mediator of MT formation in GBM through SMAD activation. TSP1 was upregulated upon TGF-ß stimulation and enhanced MT formation, which was inhibited by TSP1 shRNAs in vitro and in vivo.

CONCLUSION:

TGF-ß and its downstream mediator TSP1 are important mediators of the MT network in GBM and blocking this pathway could potentially help to break the complex MT-driven invasion/resistance network.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligodendroglioma / Glioblastoma / Glioma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligodendroglioma / Glioblastoma / Glioma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article